A detailed history of Pier Capital, LLC transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Pier Capital, LLC holds 1,589 shares of WST stock, worth $506,303. This represents 0.09% of its overall portfolio holdings.

Number of Shares
1,589
Previous 1,567 1.4%
Holding current value
$506,303
Previous $551,000 13.97%
% of portfolio
0.09%
Previous 0.08%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

BUY
$338.27 - $413.0 $7,441 - $9,086
22 Added 1.4%
1,589 $628,000
Q4 2023

Feb 15, 2024

BUY
$318.29 - $392.21 $168,057 - $207,086
528 Added 50.82%
1,567 $551,000
Q3 2023

Nov 14, 2023

SELL
$354.9 - $412.41 $7,807 - $9,073
-22 Reduced 2.07%
1,039 $389,000
Q2 2023

Aug 14, 2023

BUY
$334.63 - $382.47 $355,042 - $405,800
1,061 New
1,061 $405,000
Q2 2019

Aug 14, 2019

SELL
$111.27 - $125.15 $9.4 Million - $10.6 Million
-84,506 Closed
0 $0
Q1 2019

Apr 24, 2019

BUY
$94.53 - $110.2 $5.19 Million - $6.06 Million
54,946 Added 185.88%
84,506 $9.31 Million
Q4 2018

Feb 13, 2019

SELL
$93.0 - $123.98 $3.91 Million - $5.21 Million
-41,993 Reduced 58.69%
29,560 $2.9 Million
Q3 2018

Nov 14, 2018

BUY
$98.01 - $123.47 $119,278 - $150,262
1,217 Added 1.73%
71,553 $8.84 Million
Q2 2018

Aug 08, 2018

BUY
$83.32 - $101.88 $722,884 - $883,910
8,676 Added 14.07%
70,336 $6.98 Million
Q1 2018

May 14, 2018

BUY
$85.56 - $102.4 $80,169 - $95,948
937 Added 1.54%
61,660 $5.44 Million
Q4 2017

Feb 15, 2018

SELL
$91.65 - $101.65 $97,057 - $107,647
-1,059 Reduced 1.71%
60,723 $5.99 Million
Q3 2017

Nov 13, 2017

BUY
$84.54 - $96.75 $5.22 Million - $5.98 Million
61,782
61,782 $5.95 Million

Others Institutions Holding WST

About WEST PHARMACEUTICAL SERVICES INC


  • Ticker WST
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 74,033,000
  • Market Cap $23.6B
  • Description
  • West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...
More about WST
Track This Portfolio

Track Pier Capital, LLC Portfolio

Follow Pier Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pier Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pier Capital, LLC with notifications on news.